Profile data is unavailable for this security.
About the company
Helen of Troy Limited is a global consumer products company. The Company offers products and solutions for its customers through a diversified portfolio of brands, including OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools and Drybar. It operates in two business segments: Home & Outdoor and Beauty & Wellness. The Home & Outdoor segment provides a range of consumer products for home activities, such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on the go activities such as hydration, food storage, backpacks, and travel gear. This segment sells primarily to retailers as well as through its direct-to-consumer channel. The Beauty & Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.
- Revenue in USD (TTM)2.01bn
- Net income in USD168.59m
- Incorporated1993
- Employees1.93k
- LocationHelen of Troy LtdClarendon House, 2 Church StreetHAMILTON HM 11BermudaBMU
- Phone+1 9 152258000
- Websitehttps://www.helenoftroy.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inmode Ltd | 466.26m | 181.11m | 1.56bn | 581.00 | 8.76 | 1.87 | 8.59 | 3.35 | 2.11 | 2.11 | 5.42 | 9.87 | 0.5973 | 1.71 | 16.09 | 802,509.40 | 23.20 | 31.32 | 25.21 | 35.64 | 83.10 | 84.46 | 38.84 | 39.65 | 12.66 | -- | 0.00 | 0.00 | 8.32 | 37.49 | 22.54 | 54.65 | 13.10 | -- |
| LeMaitre Vascular Inc | 199.89m | 33.95m | 1.79bn | 614.00 | 52.72 | 5.79 | 41.07 | 8.94 | 1.51 | 1.51 | 8.89 | 13.74 | 0.5977 | 1.17 | 7.19 | 325,548.90 | 10.15 | 9.02 | 10.99 | 9.93 | 66.45 | 65.83 | 16.99 | 15.45 | 5.31 | -- | 0.00 | 40.41 | 19.69 | 12.88 | 45.89 | 5.96 | 18.93 | 15.51 |
| UFP Technologies Inc | 407.33m | 47.88m | 1.89bn | 3.09k | 39.79 | 6.42 | 31.84 | 4.65 | 6.21 | 6.21 | 52.82 | 38.46 | 1.02 | 4.50 | 6.71 | 131,693.20 | 11.99 | 9.69 | 13.80 | 10.95 | 27.89 | 26.33 | 11.75 | 10.14 | 1.46 | 17.87 | 0.1039 | 0.00 | 13.08 | 16.00 | 7.50 | 25.71 | 14.08 | -- |
| Premier Inc | 1.34bn | 80.33m | 2.00bn | 2.80k | 29.65 | 1.04 | 10.14 | 1.49 | 0.6421 | 0.6421 | 11.34 | 18.35 | 0.3887 | 5.25 | 3.10 | 477,306.10 | 1.89 | 10.39 | 2.48 | 13.00 | 66.20 | 62.04 | 4.87 | 22.60 | 0.8226 | 143.62 | 0.276 | 19.11 | -6.76 | 2.44 | -34.17 | -15.30 | -2.29 | -- |
| Warby Parker Inc | 697.80m | -55.06m | 2.00bn | 2.14k | -- | 6.31 | -- | 2.86 | -0.467 | -0.467 | 5.91 | 2.66 | 1.21 | 5.19 | 655.52 | 326,074.80 | -9.57 | -- | -11.95 | -- | 55.01 | 57.49 | -7.89 | -14.53 | 2.02 | -- | 0.00 | -- | 11.98 | 19.67 | 42.75 | -- | -- | -- |
| STAAR Surgical Co | 326.24m | 15.30m | 2.07bn | 1.06k | 136.33 | 5.27 | 100.10 | 6.35 | 0.3093 | 0.3093 | 6.62 | 8.00 | 0.7159 | 2.11 | 5.09 | 308,942.30 | 3.36 | 6.77 | 3.82 | 7.90 | 78.51 | 76.89 | 4.69 | 9.16 | 5.22 | -- | 0.0004 | 0.00 | 13.37 | 21.07 | -46.18 | 33.85 | 51.95 | -- |
| Patterson Companies, Inc. | 6.57bn | 193.86m | 2.13bn | 7.60k | 11.74 | 2.21 | 7.62 | 0.3249 | 2.03 | 2.03 | 68.86 | 10.78 | 2.23 | 5.61 | 14.48 | 864,047.90 | 6.58 | 0.3702 | 11.30 | 0.5655 | 21.30 | 21.05 | 2.95 | 0.1811 | 0.7243 | 12.08 | 0.4462 | 846.10 | -0.4298 | 3.44 | 2.14 | 10.79 | 8.22 | 0.00 |
| Conmed Corp | 1.26bn | 82.35m | 2.25bn | 4.00k | 27.88 | 2.63 | 14.59 | 1.78 | 2.62 | 2.62 | 40.12 | 27.76 | 0.545 | 1.73 | 5.55 | 315,387.00 | 3.56 | 0.8972 | 4.10 | 1.02 | 54.92 | 54.95 | 6.53 | 1.65 | 1.08 | 3.65 | 0.5369 | 139.16 | 19.06 | 7.68 | 179.99 | 10.04 | 2.89 | 0.00 |
| Helen of Troy Limited | 2.01bn | 168.59m | 2.47bn | 1.93k | 14.69 | 1.50 | 11.20 | 1.23 | 7.05 | 7.05 | 83.65 | 68.94 | 0.6971 | 2.48 | 5.19 | 1,040,503.00 | 5.86 | 7.69 | 6.90 | 9.53 | 47.31 | 44.32 | 8.41 | 9.24 | 0.9936 | 5.27 | 0.289 | -- | -3.26 | 5.09 | 17.67 | -0.6548 | 6.79 | -- |
| ICU Medical Inc | 2.26bn | -59.31m | 2.54bn | 14.00k | -- | 1.23 | 14.92 | 1.13 | -2.46 | -2.46 | 93.27 | 84.87 | 0.5154 | 2.12 | 15.86 | 161,223.70 | -1.35 | 1.46 | -1.51 | 1.65 | 32.48 | 34.11 | -2.63 | 2.23 | 1.09 | 0.4817 | 0.4393 | 0.00 | -0.9154 | 10.04 | 60.08 | -- | -1.45 | -- |
| Enovis Corp | 1.82bn | -103.33m | 2.74bn | 6.55k | -- | 0.8293 | 20.22 | 1.51 | -1.89 | -1.50 | 33.29 | 60.33 | 0.3717 | 1.49 | 5.49 | 277,452.20 | -2.10 | -0.3569 | -2.32 | -0.41 | 58.12 | 48.19 | -5.66 | -1.06 | 1.03 | 0.9243 | 0.2879 | -- | 9.22 | -4.89 | -40.29 | -- | 11.91 | -- |
| Inari Medical Inc | 520.66m | -23.62m | 2.76bn | 1.30k | -- | 6.15 | -- | 5.30 | -0.409 | -0.409 | 8.95 | 7.71 | 0.8913 | 1.58 | 7.75 | 400,506.90 | -4.04 | -0.5941 | -4.57 | -0.6696 | 87.67 | 89.06 | -4.54 | -0.6295 | 2.19 | -- | 0.00 | -- | 28.73 | 135.40 | 94.41 | -- | 52.46 | -- |
| Envista Holdings Corp | 2.56bn | -120.40m | 3.09bn | 12.80k | -- | 0.7461 | 283.33 | 1.21 | -0.713 | -0.713 | 14.72 | 24.09 | 0.3904 | 3.89 | 6.29 | 200,226.60 | -1.83 | 1.94 | -2.15 | 2.34 | 56.35 | 57.65 | -4.70 | 5.29 | 1.93 | 5.09 | 0.2667 | 0.00 | -0.1012 | -2.04 | -142.10 | -- | -4.22 | -- |
| Tandem Diabetes Care Inc | 770.01m | -141.45m | 3.21bn | 2.40k | -- | 13.20 | -- | 4.17 | -2.17 | -2.17 | 11.82 | 3.76 | 0.8126 | 2.74 | 8.35 | 320,837.10 | -14.93 | -10.08 | -18.48 | -12.23 | 49.28 | 51.77 | -18.37 | -11.59 | 3.01 | -- | 0.5884 | -- | -6.68 | 32.39 | -135.33 | -- | 76.81 | -- |
| LivaNova PLC | 1.19bn | -31.77m | 3.22bn | 2.90k | -- | 2.63 | 191.07 | 2.71 | -0.5911 | -0.5911 | 21.89 | 22.56 | 0.4985 | 2.57 | 6.11 | 408,634.10 | -1.33 | -6.01 | -1.54 | -7.42 | 67.89 | 66.99 | -2.67 | -13.56 | 2.71 | 2.52 | 0.3383 | -- | 12.89 | 0.8278 | 120.34 | -- | -1.64 | -- |
| Procept Biorobotics Corp | 156.33m | -103.37m | 3.43bn | 626.00 | -- | 12.99 | -- | 21.95 | -2.12 | -2.12 | 3.20 | 5.14 | 0.4685 | 1.81 | 4.08 | 249,722.00 | -30.98 | -- | -34.68 | -- | 53.47 | -- | -66.12 | -- | 7.44 | -- | 0.1629 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
Data as of May 24 2024. Currency figures normalised to Helen of Troy Ltd's reporting currency: US Dollar USD
62.45%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 2.70m | 11.37% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 2.56m | 10.78% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 2.36m | 9.95% |
| Cooke & Bieler LPas of 31 Mar 2024 | 1.88m | 7.91% |
| Capital Research & Management Co. (Global Investors)as of 31 Mar 2024 | 1.09m | 4.57% |
| Dimensional Fund Advisors LPas of 31 Mar 2024 | 1.05m | 4.42% |
| Allspring Global Investments LLCas of 31 Mar 2024 | 919.39k | 3.87% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 844.08k | 3.56% |
| FIAM LLCas of 31 Mar 2024 | 745.88k | 3.14% |
| JPMorgan Investment Management, Inc.as of 31 Mar 2024 | 683.60k | 2.88% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
